PHARMAORIGIN ApS: Financial statements 2023
CVR: 29178291
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PHARMAORIGIN ApS (CVR 29178291) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 0 and a net result of DKK 87,000 compared with DKK 47,000 the year before. Equity in the 2023 report amounted to DKK 1,283,000. The solvency ratio was 100%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 87,000
- Equity
- DKK 1,283,000
- Total Assets
- DKK 1,283,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 0 | 87 t. | 1.3 mio. | - |
| 2022 | - | - | 47 t. | 1.2 mio. | - |
| 2021 | - | - | 40 t. | 1.1 mio. | - |
| 2020 | - | - | 13 t. | 1.1 mio. | - |
| 2019 | - | - | 18 t. | 1.1 mio. | 0 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PHARMAORIGIN ApS has published its annual report for 2022. The net result was DKK 47,000.
About PHARMAORIGIN ApS
PHARMAORIGIN ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named ApS KBUS 17 NR. 4503. The management consists of Danielle Marie Brown. The company is owned by Savara ApS. The company has 0 employees (2008). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 100,000 compared with DKK 94,000 the year before. Equity in the 2025 report amounted to DKK 1,477,000.